Comparison of CL Wear Between Epinastine Hydrochloride and Olopatadine Hydrochloride

NCT00489398 Phase 4 WITHDRAWN

Comparison of two allergy drops for enhancing comfort and performance of contact lens wear

Details

Lead sponsor	Hom, Milton M., OD, FAAO
Phase	Phase 4
Status	WITHDRAWN
Enrolment	25
Start date	2007-07
Completion	2008-12

Conditions

• Allergic Conjunctivitis

Interventions

• epinastine HCL and olopatadine HCL

Primary outcomes

• Contact lens objective and subjective clinical performance testing — up to 3 months